Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
7.42
-0.20 (-2.62%)
At close: May 30, 2025, 4:00 PM
7.05
-0.37 (-4.99%)
After-hours: May 30, 2025, 6:02 PM EDT
CRBP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 18.9 | 17.2 | 13.72 | 17 | 25.01 | 85.43 | Upgrade
|
| Short-Term Investments | 113.89 | 131.86 | 7.18 | 42.19 | 72.64 | - | Upgrade
|
| Cash & Short-Term Investments | 132.79 | 149.06 | 20.91 | 59.2 | 97.65 | 85.43 | Upgrade
|
| Cash Growth | 10.56% | 613.01% | -64.68% | -39.38% | 14.30% | 169.09% | Upgrade
|
| Accounts Receivable | - | - | - | - | - | 1.62 | Upgrade
|
| Other Receivables | 1.1 | - | - | - | - | 0.96 | Upgrade
|
| Receivables | 1.1 | - | - | - | - | 2.58 | Upgrade
|
| Prepaid Expenses | 3.19 | 3.63 | 2.45 | 0.79 | 2.37 | 3.71 | Upgrade
|
| Restricted Cash | 0.29 | 0.29 | 0.19 | 0.19 | 0.19 | 0.35 | Upgrade
|
| Total Current Assets | 137.36 | 152.98 | 23.55 | 60.18 | 100.2 | 92.07 | Upgrade
|
| Property, Plant & Equipment | 2.19 | 2.52 | 4.04 | 5.5 | 7 | 9.32 | Upgrade
|
| Other Long-Term Assets | 0.39 | 0.39 | 0.69 | 0.63 | 0.52 | 0.9 | Upgrade
|
| Total Assets | 139.93 | 155.88 | 28.27 | 66.31 | 107.73 | 102.29 | Upgrade
|
| Accounts Payable | 4.07 | 4.79 | 3.18 | 2.17 | 1.78 | 7.38 | Upgrade
|
| Accrued Expenses | 5.9 | 5.43 | 11.03 | 6 | 10.09 | 22.01 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 16.21 | 3.15 | 3.86 | 0.71 | Upgrade
|
| Current Portion of Leases | 1.65 | 1.61 | 1.44 | 1.28 | 1.14 | 1 | Upgrade
|
| Other Current Liabilities | - | - | 0.04 | 0.04 | 0.13 | 0.8 | Upgrade
|
| Total Current Liabilities | 11.62 | 11.82 | 31.89 | 12.64 | 17.01 | 31.9 | Upgrade
|
| Long-Term Debt | - | - | - | 15.98 | 15.64 | 18.03 | Upgrade
|
| Long-Term Leases | 1.21 | 1.63 | 3.24 | 4.68 | 5.96 | 7.09 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.04 | 0.02 | 0.02 | - | Upgrade
|
| Total Liabilities | 12.83 | 13.45 | 35.18 | 33.32 | 38.62 | 57.02 | Upgrade
|
| Common Stock | 0 | 0 | - | 0 | 0 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 621 | 619.29 | 429.78 | 425.2 | 418.9 | 349.36 | Upgrade
|
| Retained Earnings | -493.87 | -476.89 | -436.68 | -392.08 | -349.73 | -304.09 | Upgrade
|
| Comprehensive Income & Other | -0.02 | 0.04 | -0 | -0.13 | -0.06 | - | Upgrade
|
| Shareholders' Equity | 127.11 | 142.43 | -6.91 | 32.99 | 69.11 | 45.27 | Upgrade
|
| Total Liabilities & Equity | 139.93 | 155.88 | 28.27 | 66.31 | 107.73 | 102.29 | Upgrade
|
| Total Debt | 2.86 | 3.24 | 20.89 | 25.09 | 26.59 | 26.84 | Upgrade
|
| Net Cash (Debt) | 129.93 | 145.82 | 0.02 | 34.11 | 71.06 | 58.6 | Upgrade
|
| Net Cash Growth | 26.37% | 694295.24% | -99.94% | -52.00% | 21.26% | 162.73% | Upgrade
|
| Net Cash Per Share | 10.93 | 13.36 | 0.00 | 8.18 | 17.35 | 22.50 | Upgrade
|
| Filing Date Shares Outstanding | 12.24 | 12.23 | 10.49 | 4.17 | 4.17 | 4.17 | Upgrade
|
| Total Common Shares Outstanding | 12.23 | 12.18 | 4.42 | 4.17 | 4.17 | 3.3 | Upgrade
|
| Working Capital | 125.74 | 141.16 | -8.35 | 47.54 | 83.2 | 60.18 | Upgrade
|
| Book Value Per Share | 10.39 | 11.69 | -1.56 | 7.91 | 16.56 | 13.74 | Upgrade
|
| Tangible Book Value | 127.11 | 142.43 | -6.91 | 32.99 | 69.11 | 45.27 | Upgrade
|
| Tangible Book Value Per Share | 10.39 | 11.69 | -1.56 | 7.91 | 16.56 | 13.74 | Upgrade
|
| Machinery | 1.13 | 1.13 | 1.2 | 1.38 | 1.43 | 2.25 | Upgrade
|
| Leasehold Improvements | 3.33 | 3.33 | 3.33 | 3.33 | 3.33 | 4.16 | Upgrade
|
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.